{"title":"네이버 금융 ─ 뉴스 ─ 공시 메모","url":"https://finance.naver.com/news/news_list.naver?mode=LSS3D&section_id=101&section_id2=258&section_id3=406","favicon":"https://finance.naver.com/news/favicon.ico","elements":[{"title":"테고사이언스, 셀라퓨틱스바이오로부터 세포치료제 CDMO 수주 [주목 e공시]","contents":"<a href=\"/news/news_read.naver?article_id=0004622292&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=406&amp;date=20211029&amp;page=1\" title=\"테고사이언스, 셀라퓨틱스바이오로부터 세포치료제 CDMO 수주 [주목 e공시]\">테고사이언스, 셀라퓨틱스바이오로부터 세포치료제 CDMO 수주 [주목 e공시]</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004622292&office_id=015&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=406&date=20211029&page=1","retrieved":1635476741471},{"title":"안랩, 3분기 연결 영업이익 57억원…전년比 0.1%↓ [주목 e공시]","contents":"<a href=\"/news/news_read.naver?article_id=0004622239&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=406&amp;date=20211029&amp;page=1\" title=\"안랩, 3분기 연결 영업이익 57억원…전년比 0.1%↓ [주목 e공시]\">안랩, 3분기 연결 영업이익 57억원…전년比 0.1%↓ [주목 e공시]</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004622239&office_id=015&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=406&date=20211029&page=1","retrieved":1635472018650},{"title":"SK이노, 3분기 영업이익 6천185억원…윤활유사업 역대 최대 흑자(종합)","contents":"<a href=\"/news/news_read.naver?article_id=0012755516&amp;office_id=001&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=406&amp;date=20211029&amp;page=1\" title=\"SK이노, 3분기 영업이익 6천185억원…윤활유사업 역대 최대 흑자(종합)\">SK이노, 3분기 영업이익 6천185억원…윤활유사업 역대 최대 흑자(종합)</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0012755516&office_id=001&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=406&date=20211029&page=1","retrieved":1635472018653}]}